298. Hereditary pancreatitis
93 clinical trials,   168 drugs   (DrugBank: 51 drugs),   48 drug target genes,   134 drug target pathways
Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01967888 (ClinicalTrials.gov) | February 2014 | 18/10/2013 | Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation | A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Assignment Study to Assess the Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation | Pancreatectomy for Chronic Pancreatitis | Drug: Reparixin;Drug: Placebo | Dompé Farmaceutici S.p.A | NULL | Completed | 18 Years | N/A | All | 104 | Phase 2;Phase 3 | United States;Canada |